Hasten Biopharmaceutic Co. Ltd. is an innovative medical and healthcare enterprise based in Hefei, China. The company integrates research, development, production, and commercial promotion of biopharmaceutical products for the industrial supply chain. With a focus on cardiovascular and metabolism diseases, Hasten Biopharmaceutic aims to build a leading position in chronic disease and age-related disease management. Their product pipeline includes Anidin for cardiovascular disease and Basexin for metabolism conditions.